202 related articles for article (PubMed ID: 18853174)
1. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
Jeschke U; Mylonas I; Kunert-Keil C; Stahn R; Scholz C; Janni W; Kuhn C; Schröder E; Mayr D; Friese K
Histochem Cell Biol; 2009 Feb; 131(2):283-95. PubMed ID: 18853174
[TBL] [Abstract][Full Text] [Related]
2. Oligosaccharides modulate the apoptotic activity of glycodelin.
Jayachandran R; Radcliffe CM; Royle L; Harvey DJ; Dwek RA; Rudd PM; Karande AA
Glycobiology; 2006 Nov; 16(11):1052-63. PubMed ID: 16854946
[TBL] [Abstract][Full Text] [Related]
3. Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
Tsviliana A; Mayr D; Kuhn C; Kunze S; Mylonas I; Jeschke U; Friese K
Anticancer Res; 2010 May; 30(5):1637-40. PubMed ID: 20592354
[TBL] [Abstract][Full Text] [Related]
4. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.
Kämäräinen M; Leivo I; Koistinen R; Julkunen M; Karvonen U; Rutanen EM; Seppälä M
Am J Pathol; 1996 May; 148(5):1435-43. PubMed ID: 8623915
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer-derived glycodelin impairs in vitro dendritic cell maturation.
Scholz C; Rampf E; Toth B; Brunnhuber R; Weissenbacher T; Friese K; Jeschke U
J Immunother; 2009 Jun; 32(5):492-7. PubMed ID: 19609241
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a polyclonal antipeptide antibody to human glycodelin.
Poddar AS; Kim JG; Gill KP; Bates BN; Santanam N; Rock JA; Murphy AA; Parthasarathy S
Fertil Steril; 1998 Mar; 69(3):543-8. PubMed ID: 9531894
[TBL] [Abstract][Full Text] [Related]
7. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
Jeschke U; Bischof A; Speer R; Briese V; Richter DU; Bergemann C; Mylonas I; Shabani N; Friese K; Karsten U
Anticancer Res; 2005; 25(3A):1581-9. PubMed ID: 16033064
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues.
Jeschke U; Kuhn C; Mylonas I; Schulze S; Friese K; Mayr D; Speer R; Briese V; Richter DU; Haase M; Karsten U
Histopathology; 2006 Mar; 48(4):394-406. PubMed ID: 16487361
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.
Lenhard M; Heublein S; Kunert-Keil C; Vrekoussis T; Lomba I; Ditsch N; Mayr D; Friese K; Jeschke U
BMC Cancer; 2013 Dec; 13():616. PubMed ID: 24377825
[TBL] [Abstract][Full Text] [Related]
10. Effects of differential glycosylation of glycodelins on lymphocyte survival.
Lee CL; Pang PC; Yeung WS; Tissot B; Panico M; Lao TT; Chu IK; Lee KF; Chung MK; Lam KK; Koistinen R; Koistinen H; Seppälä M; Morris HR; Dell A; Chiu PC
J Biol Chem; 2009 May; 284(22):15084-96. PubMed ID: 19240032
[TBL] [Abstract][Full Text] [Related]
11. Differences in glycosylation and sperm-egg binding inhibition of pregnancy-related glycodelin.
Koistinen H; Easton RL; Chiu PC; Chalabi S; Halttunen M; Dell A; Morris HR; Yeung WS; Seppala M; Koistinen R
Biol Reprod; 2003 Nov; 69(5):1545-51. PubMed ID: 12826581
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss.
Jeschke U; Toth B; Scholz C; Friese K; Makrigiannakis A
J Reprod Immunol; 2010 May; 85(1):99-105. PubMed ID: 20299109
[TBL] [Abstract][Full Text] [Related]
13. Glycodelin-A stimulates interleukin-6 secretion by human monocytes and macrophages through L-selectin and the extracellular signal-regulated kinase pathway.
Lee CL; Lam EY; Lam KK; Koistinen H; Seppälä M; Ng EH; Yeung WS; Chiu PC
J Biol Chem; 2012 Oct; 287(44):36999-7009. PubMed ID: 22977256
[TBL] [Abstract][Full Text] [Related]
14. Differential actions of glycodelin-A on Th-1 and Th-2 cells: a paracrine mechanism that could produce the Th-2 dominant environment during pregnancy.
Lee CL; Chiu PC; Lam KK; Siu SO; Chu IK; Koistinen R; Koistinen H; Seppälä M; Lee KF; Yeung WS
Hum Reprod; 2011 Mar; 26(3):517-26. PubMed ID: 21227941
[TBL] [Abstract][Full Text] [Related]
15. Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion.
Jeschke U; Wang X; Briese V; Friese K; Stahn R
Histochem Cell Biol; 2003 May; 119(5):345-54. PubMed ID: 12743827
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the immunomodulatory activity of glycodelin.
Karande AA; Mukhopadhyay D; Jayachandran R; Sundarraj S; Alok A
Indian J Physiol Pharmacol; 2005; 49(3):271-83. PubMed ID: 16440844
[TBL] [Abstract][Full Text] [Related]
17. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract][Full Text] [Related]
18. Glycodelin: a reproduction-related lipocalin.
Halttunen M; Kämäräinen M; Koistinen H
Biochim Biophys Acta; 2000 Oct; 1482(1-2):149-56. PubMed ID: 11058757
[TBL] [Abstract][Full Text] [Related]
19. Glycodelins.
Seppälä M; Bohn H; Tatarinov Y
Tumour Biol; 1998; 19(3):213-20. PubMed ID: 9591048
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of an immunomodulatory endometrial protein, glycodelin.
Vigne JL; Hornung D; Mueller MD; Taylor RN
J Biol Chem; 2001 May; 276(20):17101-5. PubMed ID: 11278680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
